Detalhe da pesquisa
1.
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
Eur J Haematol
; 107(5): 529-542, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270825
2.
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.
Eur J Haematol
; 103(3): 255-267, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231828
3.
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
Br J Haematol
; 179(4): 586-597, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961309
4.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica
; 101(11): 1398-1406, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662018
5.
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.
Br J Haematol
; 168(4): 507-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25302557
6.
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial.
Haematologica
; 97(5): 784-91, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22133776
7.
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.
Haematologica
; 97(8): 1272-7, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22371180
8.
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).
Blood
; 113(18): 4137-43, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19182205
9.
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM.
Cancers (Basel)
; 13(6)2021 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33809431
10.
Linear dichroism in the XANES of partially oriented samples: theory and application to the photosynthetic manganese complex.
Chemphyschem
; 11(6): 1236-47, 2010 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20391456
11.
The G-Allele of the PSMA6-8C>G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels.
Eur J Haematol
; 85(2): 108-13, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20408869
12.
DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma.
Ann Hematol
; 88(11): 1125-30, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19274460
13.
Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients.
Eur J Haematol
; 83(6): 519-27, 2009 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19614956
14.
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.
Leukemia
; 33(11): 2710-2719, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462732
15.
Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.
Eur J Haematol
; 80(6): 490-4, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18331598
16.
Cytogenetics and molecular cytogenetics in multiple myeloma.
Eur J Cancer
; 42(11): 1520-9, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16781866
17.
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
Haematologica
; 90(4): 489-93, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15820944
18.
Prognostic significance of serum cystatin C in multiple myeloma.
Int J Hematol
; 95(5): 545-50, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22426688
19.
Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.
Appl Immunohistochem Mol Morphol
; 17(2): 96-101, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18838917
20.
RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.
Blood
; 111(3): 1357-65, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17978170